Cargando…
Biomarkers to guide the use of antibiotics for acute exacerbations of COPD (AECOPD): a systematic review and meta-analysis
BACKGROUND: Antibiotics are frequently prescribed for acute exacerbations of COPD (AECOPD) even though most do not have a bacterial aetiology. Biomarkers may help clinicians target antibiotic use by identifying AECOPD caused by bacterial pathogens. We aimed to summarise current evidence on the diagn...
Autores principales: | Hoult, George, Gillespie, David, Wilkinson, Tom M. A., Thomas, Mike, Francis, Nick A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9101830/ https://www.ncbi.nlm.nih.gov/pubmed/35549921 http://dx.doi.org/10.1186/s12890-022-01958-4 |
Ejemplares similares
-
Antimicrobial therapies for prevention of recurrent acute exacerbations of COPD (AECOPD): beyond the guidelines
por: Brennan, Michelle, et al.
Publicado: (2022) -
Is Acute Exacerbation of COPD (AECOPD) Related to Viral Infection Associated with Subsequent Mortality or Exacerbation Rate?
por: Kherad, Omar, et al.
Publicado: (2014) -
Acute exacerbations of copd (AECOPD) in the emergency room (ER): prognostic value of proadrenomedulline (PROADM)
por: Dres, M, et al.
Publicado: (2015) -
Policy during coronavirus disease 2019 (COVID-19) pandemic: a protector for acute exacerbation of COPD (AECOPD) patients?
por: Zeng, Yuqin, et al.
Publicado: (2021) -
CircRNA0001859, a new diagnostic and prognostic biomarkers for COPD and AECOPD
por: Chen, Shuifang, et al.
Publicado: (2020)